DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line

World Journal of Gastroenterology

Volumn 8, Issue 5, 2002, Pages 797-803

  Zeng, Zhao Chong ^a   Jiang, Guo Liang ^a   Wang, Guo Min ^a   Tang, Zhao You ^a   Curran, Walter J ^a   Iliakis, George ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; WORTMANNIN;

ALPHA RADIATION; ARTICLE; BETA RADIATION; CELL KILLING; CELL STRAIN HEPG2; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SUBUNIT; EXTRACTION; GEL ELECTROPHORESIS; HEAT TREATMENT; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; LIVER CELL CARCINOMA; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; RADIOSENSITIZATION; THERMAL EXPOSURE;

EID: 0036790510     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i5.797     Document Type: Article

References (56)

1. Niu Q, Tang ZY, Ma ZC, Qin LX, Zhang LH. Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 2000;6:565-568
2. Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Ye SL. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol 2001;7:28-32
3. Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001;7:208-215
4. Wu MC, Shen F. Progress in research of liver surgery in China. World J Gastroenterol 2001;6:773-776
5. Yip D, Findlay M, Boyer M, Tattersall MH. Hepatocellular carcinoma in central Sydney: a 10-year review of patients see in a medical oncology department. World J Gastroenterol 1999;5:483-487
6. Lu MD, Chen JW, Xie XY, Liang LJ, Huang JF. Portal vein embolization by fine needle ethanol injection: experimental and clinical studies. World J Gastroenterol 1999;5:506-510
7. Jiang YF, Yang ZH, Hu JQ. Recurrence or metastasis of HCC: predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 2000;6:61-65
8. Wu ZQ, Fan J, Qiu SJ, Zhou J, Tang ZY. The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer. World J Gastroenterol 2000;6:131-133
9. Sithinamsuwan P, Piratvisuth T, Tanomkiat W, Apakupakul N, Tongyoo S. Review of 336 patients with hepatocellular carcinoma at Songklanagarind hospital. World J Gastroenterol 2000;6:339-343
10. Tang ZY, Sun FX, Tian J, Ye SL, Liu YK, Liu KD, Xue Q, Chen J, Xia JL, Qin LX, Sun HC, Wang L, Zhou J, Li Y, Ma ZC, Zhou XD, Wu ZQ, Lin ZY, Yang BH. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. World J Gastroenterol 2001;7:597-601
11. Bramhall SR, Minford E, Gunson B, Buckels JAC. Liver transplantation in the UK. World J Gastroenterol 2001;7:602-611
12. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001;7:630-636
13. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001;7:445-454
14. Wang JH, Lin G, Yan ZP, Wang XL, Cheng JM, Li MQ. Stage II surgical resection of hepatocellular carcinoma after TAE: a report of 38 cases. World J Gastroenterol 1998;4:133-136
15. Li L, Wu PH, Li JQ, Zhang WZ, Lin HG, Zhang YQ. Segmental transcatheter arterial embolization for primary hepatocellular carcinoma. World J Gastroenterol 1998;4:511-512
16. Zheng N, Ye SL, Sun RX, Zhao Y, Tang ZY. Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma. World J Gastroenterol 2002;8:233-236
17. Qin LX, Tang ZY, Ma ZC, Wu ZQ, Zhou XD, Ye QH, Ji Y, Huang LW, Jia HL, Sun HC, Wang L. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. World J Gastroenterol 2002;8:459-463
18. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002;8:385-392
19. Zhang G, Long M, Wu ZZ, Yu WQ. Mechanical properties of hepatocellular carcinoma cells. World J Gastroenterol 2002;8:243-246
20. Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002;8:237-242
21. Zeng ZC, Tang ZY, Wu ZQ, Ma ZC, Fan J, Qin LX, Zhou J, Wang JH, Wang BL, Zhong CS. Phase I clinical trial of oral furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers, including clinicopathologic study. Am J Clin Oncol 2000;23:449-454
22. 131I-anti-HCC mAb. Phase I/II clinical trials. J Cancer Res Clin Oncol 1998;124:275-80
23. Zeng ZC, Tang ZY, Liu KD, Yu YQ, Yang BH, Cai XJ, Xie H, Cao SL. Observation of changes in peripheral T-lymphocyte subsets by flow cytometry in patients with liver cancer treated with radioimmunotherapy. Nucl Med Commun 1995;16:378-385
24. Liu H, Wang Y, Zhou Q, Gui SY, Li X. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China. World J Gastroenterol 2002;8:480-482
25. Zeng ZC, Tang ZY, Liu KD, Lu JZ, Cai XJ, Xie H. Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion. Cancer Immunol Immunother 1994;39:332-336
26. Zeng ZC, Tang ZY, Xie H, Liu KD, Lu JZ, Chai XJ, Wang GF, Yao Z, Qian JM. Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results. J Cancer Res Clin Oncol 1993;119:257-259
27. Liu LX, Jiang HC, Piao DX. Radiofrequence ablation of liver cancers. World J Gastroenterol 2002;8:393-399
28. Seong J, Keum KC, Han KH, Lee DY, Lee JT, Chon CY, Moon YM, Suh CO, Kim GE. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiation Oncol Biol Phys 1999;43:393-397
29. Tang ZY, Yu YQ, Zhou XD, Ma ZC, Yang BH, Lin ZY, Lu JZ, Liu KD, Fan Z, Zeng ZC. Treatment of unresectable primary liver cancer: with reference to cytoreduction and sequential resection. World J Surg 1995;19:47-52
30. Nagata Y, Hiraoka M, Nishimura Y, Masunaga S, Mitumori M, Okuno Y, Fujishiro M, Kanamori S, Horii N, Akuta K, SaSai K, Abe M, Fukuda Y. Clinical results of radiofrequency hyperthermia for malignant liver tumor. Int. J Radiat Oncol Biol Phys 1997;38:359-365
31. Seong J, Lee HS, Han KH, Chon CY, Suh Co, Kim GE. Combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma. Yonsei Med J 1994;35:252-259
32. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec M, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH. Survival benefit of hyperthermia in a prospective randomize trial of brachytherapy boost? hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998;40:287-295
33. Hall EJ. Hyperthermia. In: Hall E.J., eds. Radiobiology for the radiologist. Philadelphia: J B Lippincott 1994: 278-281
34. Iliakis G, Seaner R. A DNA double-strand break repair-deficient mutant of CHO cells shows reduced radiosensitization after exposure to hyperthermic temperatures in the plateau phase of growth. Int J Hyperthermia 1990;6:801-812
35. El-Awady RA, Dikomey E, Dahm-Daphi J. Heat effects on DNA repair after ionising radiation: Hyperthermia commonly increases the number of non-repaired double-strand breaks and structural rearrangements. Nucleic Acids 2001;29:1960-1966
36. Kampinga HH, Dikomey E. Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol 2001;77:399-408
37. Raaphorst GP. Recovery of sublethal radiation damage and its inhibition by hyperthermia in normal and transformed mouse cells. Int J Radiat Oncol Biol Phys 1992;22:1035-1041
38. Raaphorst GP, Feeley MM. Hyperthermia radiosensitization in human glioma cells comparison of recovery of polymerase activity, survival, and potentially lethal damage repair. Int J Radiat Oncol Biol Phys 1994;29:133-139
39. Smith GCM, Jackson SP. The DNA-dependent protein kinase. Genes Devel 1999;13:916-934
40. Matsumoto Y, Suzuki N, Sakai K, Morimatsu A, Hirano K, Murofushi H. A possible mechanism for hyperthermic radiosensitization mediated through hyperthermic lability of Ku subunits in DNA-dependent protein kinase. Biochem Biophys Res Commun 1997;234:568-572
41. Iliakis G, Metzger L, Denko N, Stamato TD. Detection of DNA double strand breaks in synchronous cultures of CHO cells by means of asymmetric field inversion gel electrophoresis. Int J Radiat Biol 1991;59:321-341
42. Metzger L, Iliakis G. Kinetics of DNA double strand breaks throughout the cell cycle as assayed by pulsed field gel electrophoresis in CHO cells. Int J Radiat Biol 1991;59:1325-1339
43. Ihara M, Suwa A, Komatsu K, Shimasaki T, Okaichi K, Hendrickson EA, Okumura Y. Heat sensitivity of double-stranded DNA-dependent protein kinase activity. Int J Radiat Biol 1999;75:253-258
44. Woudstra EC, Konings A.WT, Jeggo PA, Kampinga HH. Role of DNA-PKcs subunits in radiosensitization by hyperthermia. Radiat Res 1999;152:214-218
45. Gottlieb TM, Jackson SP. The DNA-dependent protein kinase: Requirement of DNA ends and association with Ku antigen. Cell 1993;72:131-142
46. Wang H, Zeng ZC, Bui TA, Sonoda E, Takata M, Takeda S, Iliakis G. Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group. Oncogene 2001;20:2212-2224
47. Wang H, Zeng ZC, Perrault AR, Cheng X, Qin W, Iliakis G. Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells. Nucleic Acids Res 2001;29:1653-1660
48. Hu B, Zhou XY, Wang X, Zeng ZC, Iliakis G, Wang Y. The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway. J Biol Chem 2001;276:17693-17698
49. Wang H, Zeng ZC, Bui TA, DiBiase SJ, Qin W, Xia F, Powell SN, Iliakis G. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res 2001;61:270-277
50. Asaad NA, Zeng ZC, Guan J, Thacker J, Iliakis G. Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants. Oncogene 2000;19:5788-5800
51. DiBiase SJ, Zeng ZC, Chen R, Hyslop T, Curran WJ Jr, Iliakis G. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res 2000;60:1245-1253
52. Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, Pirola lL, Vanhaesebroeck B, Waterfield MD, and Panayotou G. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Molec Cell Biol 1996;16:1722-1733
53. Roth DB, Wilson JH. Relative rates of homologous and nonhomologous recombination in transfected DNA. Proc Natl Acad Sci USA 1985;82:3355-3359
54. Suzuki K, Kodama S, Watanabe M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J Biol Chem 1999;274:25571-25575
55. Withers HR, McBride WH. Biologic basis of radiation therapy. In: Perez C, Brady L.W., eds: Principles & Practice of Radiation Oncology. Philadelphia: Lippincott-Raven 1998:91
56. Hall EJ. Hyperthermia. In: Hall E.J., eds. Radiobiology for the radiologist. Philadelphia: J B Lippincott 1994:271-272